Hospital outbreak of Pseudomonas aeruginosa producing extended-spectrum oxacillinase OXA-19

References

1. Aubert D., Girlich D., Naas T., Nagarajan S., Nordmann P. 2004; Functional and structural characterization of the genetic environment of an extended-spectrum β -lactamase bla _VEB gene from a Pseudomonas aeruginosa isolate obtained in India. Antimicrob Agents Chemother 48:3284–3290 [CrossRef]
   [Google Scholar]
2. Bert F., Branger C., Lambert-Zechovsky N. 2002; Identification of PSE and OXA β -lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J Antimicrob Chemother 50:11–18 [CrossRef]
   [Google Scholar]
3. Bertrand X., Bailly P., Blasco G., Balvay P., Boillot A., Talon D. 2000; Large outbreak in a surgical intensive care unit of colonization or infection with Pseudomonas aeruginosa that overexpressed an active efflux pump. Clin Infect Dis 31:E9–E14 [CrossRef]
   [Google Scholar]
4. Bertrand X., Thouverez M., Talon D., Boillot A., Capellier G., Floriot C., Helias J. P. 2001; Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Med 27:1263–1268 [CrossRef]
   [Google Scholar]
5. Carmeli Y., Troillet N., Karchmer A. W., Samore M. H. 1999; Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa . Arch Intern Med 159:1127–1132 [CrossRef]
   [Google Scholar]
6. Fluit A. C., Schmitz F. J. 2004; Resistance integrons and super-integrons. Clin Microbiol Infect 10:272–288 [CrossRef]
   [Google Scholar]
7. Hocquet D., Bertrand X., Kohler T., Talon D., Plesiat P. 2003; Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrob Agents Chemother 47:1887–1894 [CrossRef]
   [Google Scholar]
8. Hocquet D., Thouverez M., Legrand F., Bertrand X., Plesiat P. 2008; Modulation of extended-spectrum beta-lactamase expression in response to antibiotic chemotherapy. In Abstracts of the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/46th Annual Meeting of the Infectious Diseases Society of America , Abstract C1-118 Washington DC: American Society for Microbiology, Infectious Diseases Society of America;
   [Google Scholar]
9. Jiang X., Zhang Z., Li M., Zhou D., Ruan F., Lu Y. 2006; Detection of extended-spectrum β -lactamases in clinical isolates of Pseudomonas aeruginosa . Antimicrob Agents Chemother 50:2990–2995 [CrossRef]
   [Google Scholar]
10. Levesque C., Piche L., Larose C., Roy P. H. 1995; PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 39:185–191 [CrossRef]
    [Google Scholar]
11. Livermore D. M. 2002; Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa : our worst nightmare?. Clin Infect Dis 34:634–640 [CrossRef]
    [Google Scholar]
12. Mugnier P., Casin I., Bouthors A. T., Collatz E. 1998; Novel OXA-10-derived extended-spectrum β -lactamases selected in vivo or in vitro. Antimicrob Agents Chemother 42:3113–3116
    [Google Scholar]
13. Poirel L., Naas T., Nordmann P. 2010; Diversity, epidemiology and genetics of class D β -lactamases. Antimicrob Agents Chemother 54:24–38 [CrossRef]
    [Google Scholar]
14. Rossolini G. M., Mantengoli E., Docquier J. D., Musmanno R. A., Coratza G. 2007; Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains. New Microbiol 30:332–339
    [Google Scholar]
15. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B. 1995; Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239
    [Google Scholar]
16. Weldhagen G. F., Poirel L., Nordmann P. 2003; Ambler class A extended-spectrum β -lactamases in Pseudomonas aeruginosa : novel developments and clinical impact. Antimicrob Agents Chemother 47:2385–2392 [CrossRef]
    [Google Scholar]